Pharmaceutical Investments Amidst Global Strategies

This chapter explores the lobbying efforts of pharmaceutical companies, with a focus on AstraZeneca's investment strategy in the U.S. and China. It highlights the challenges and opportunities these companies face in navigating domestic and global interests while engaging with high-level political figures.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app